These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 37747270)
21. Capillary electrophoresis/immunosubtraction as a better alternative to immunofixation for detecting and immunotyping serum monoclonal proteins in patients with immunoglobulin light chain (AL) amyloidosis. Miyazaki K; Suzuki K Amyloid; 2016 Dec; 23(4):221-224. PubMed ID: 27682970 [TBL] [Abstract][Full Text] [Related]
24. Utility of the Serum Free Light Chain Assay in the Diagnosis of Light Chain Amyloidosis in Patients With Heart Failure. Chang IC; Dispenzieri A; Scott CG; Lin G; Jaffe AS; Klarich KW; Grogan M Mayo Clin Proc; 2019 Mar; 94(3):447-454. PubMed ID: 30718069 [TBL] [Abstract][Full Text] [Related]
25. Molecular Mechanism of Pathogenesis and Treatment Strategies for AL Amyloidosis. Ikura H; Endo J; Kitakata H; Moriyama H; Sano M; Fukuda K Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35683015 [TBL] [Abstract][Full Text] [Related]
26. Immunoglobulin free light chains in saliva: a potential marker for disease activity in multiple sclerosis. Kaplan B; Golderman S; Ganelin-Cohen E; Miniovitch A; Korf E; Ben-Zvi I; Livneh A; Flechter S Clin Exp Immunol; 2018 Apr; 192(1):7-17. PubMed ID: 29194592 [TBL] [Abstract][Full Text] [Related]
27. The use of serum free light chain dimerization patterns assist in the diagnosis of AL amyloidosis. Gatt ME; Kaplan B; Yogev D; Slyusarevsky E; Pogrebijski G; Golderman S; Kukuy O; Livneh A Br J Haematol; 2018 Jul; 182(1):86-92. PubMed ID: 29767409 [TBL] [Abstract][Full Text] [Related]
28. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma. Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850 [TBL] [Abstract][Full Text] [Related]
29. The impact of renal function on the clinical performance of FLC measurement in AL amyloidosis. Palladini G; Milani P; Foli A; Basset M; Russo F; Bosoni T; Pirolini L; Valentini V; Ferraro G; Lavatelli F; Barassi A; Albertini R; Merlini G Clin Chem Lab Med; 2016 Jun; 54(6):939-45. PubMed ID: 26943606 [TBL] [Abstract][Full Text] [Related]
30. Serum free light chain analysis may miss monoclonal light chains that urine immunofixation electrophoreses would detect. Shaheen SP; Levinson SS Clin Chim Acta; 2009 Aug; 406(1-2):162-6. PubMed ID: 19410572 [TBL] [Abstract][Full Text] [Related]
31. Circulating free light chain measurement in the diagnosis, prognostic assessment and evaluation of response of AL amyloidosis: comparison of Freelite and N latex FLC assays. Palladini G; Jaccard A; Milani P; Lavergne D; Foli A; Bender S; Lavatelli F; Bosoni T; Valentini V; Pirolini L; Ferraro G; Basset M; Russo F; Nuvolone M; Albertini R; Cogne M; Merlini G Clin Chem Lab Med; 2017 Oct; 55(11):1734-1743. PubMed ID: 28343171 [TBL] [Abstract][Full Text] [Related]
32. Mutations in specific structural regions of immunoglobulin light chains are associated with free light chain levels in patients with AL amyloidosis. Poshusta TL; Sikkink LA; Leung N; Clark RJ; Dispenzieri A; Ramirez-Alvarado M PLoS One; 2009; 4(4):e5169. PubMed ID: 19365555 [TBL] [Abstract][Full Text] [Related]
33. The Role of Light Kappa and Lambda Chains in Heart Function Assessment in Patients with AL Amyloidosis. Czyżewska E; Wiśniewska A; Waszczuk-Gajda A; Ciepiela O J Clin Med; 2021 Mar; 10(6):. PubMed ID: 33803904 [TBL] [Abstract][Full Text] [Related]
34. A novel approach for the chromatographic purification and peptide mass fingerprinting of urinary free light chains. Mali BC; Badgujar SB; Shukla KK; Bhanushali PB Int J Biol Macromol; 2017 Feb; 95():331-339. PubMed ID: 27888009 [TBL] [Abstract][Full Text] [Related]
35. Free light chain UV quantification compared with immunochemical measurement: How dimers and monomers may influence the results. Caponi L; Koni E; Romiti N; Paolicchi A; Franzini M Clin Chim Acta; 2020 Nov; 510():278-284. PubMed ID: 32702433 [TBL] [Abstract][Full Text] [Related]
36. Mass spectrometry-based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis. Sethi S; Theis JD; Leung N; Dispenzieri A; Nasr SH; Fidler ME; Cornell LD; Gamez JD; Vrana JA; Dogan A Clin J Am Soc Nephrol; 2010 Dec; 5(12):2180-7. PubMed ID: 20876678 [TBL] [Abstract][Full Text] [Related]
37. Serum monoclonal immunoglobulin light-chain detection differs between immunofixation electrophoresis methods in patients with AL amyloidosis. Kawano Y; Nishimura N; Yasunaga JI Int J Hematol; 2024 Aug; 120(2):212-216. PubMed ID: 38739302 [TBL] [Abstract][Full Text] [Related]
38. Isolation and biochemical characterization of plasma monoclonal free light chains in amyloidosis and multiple myeloma: a pilot study of intact and truncated forms of light chains and their charge properties. Kaplan B; Ramirez-Alvarado M; Dispenzieri A; Zeldenrust SR; Leung N; Livneh A; Gallo G Clin Chem Lab Med; 2008; 46(3):335-41. PubMed ID: 18254719 [TBL] [Abstract][Full Text] [Related]
39. In vitro co-expression of human amyloidogenic immunoglobulin light and heavy chain proteins: a relevant cell-based model of AL amyloidosis. Klimtchuk ES; Prokaeva TB; Spencer BH; Gursky O; Connors LH Amyloid; 2017 Jun; 24(2):115-122. PubMed ID: 28632419 [TBL] [Abstract][Full Text] [Related]